---
title: Predict checkpoint inhibitor benefit with new Immunotherapy Response Score (IRS) - TD2 Precision Oncology
description: TD2’s clinical oncology expert co-authors “Development and validation of an integrative pan-solid tumor predictor of PD-1/PD-L1 blockade benefit.”
image: https://td2inc.com/hubfs/Assets/Images/blocking-pd-l1.png
---
×
[](https://td2inc.com/?hsLang=en)
[](https://td2inc.com/?hsLang=en)
# Biomarkers predict response to checkpoint inhibitor PD-1/PD-L1 antibody treatment
TD2 Chief Medical Officer, Dr. Alan Miller, collaborates with other oncology experts in this *Communications Medicine* article “Development and validation of an integrative pan-solid tumor predictor of PD-1/PD-L1 blockade benefit.”
Key Takeaways from this paper are:
- Outcomes and genomic data help guide the development of this novel IRS.
- Predictive response is shown to PD-1/PD-L1 treatment in a sub-set of patients.
- Implementation has the potential to expand treatment benefits to new indications.
Tomlins, S. A., Khazanov, N. A., Bulen, B. J., Hovelson, D. H., Shreve, M. J., Lamb, L. E., Matrana, M. R., Burkard, M. E., Yang, E. S.-H., Edenfield, W. J., Dees, E. C., Onitilo, A. A., Thompson, M., Buchschacher, G. L., **Miller, A. M.**, Menter, A., Parsons, B., Wassenaar, T., Hwang, L. C., … Rhodes, D. R. (2023). Development and validation of an integrative pan-solid tumor predictor of PD-1/PD-L1 blockade benefit. *Communications Medicine*, 3(1). [https://doi.org/10.1038/s43856-023-00243-7](https://doi.org/10.1038/s43856-023-00243-7)
[Download Now](https://td2inc.com/hubfs/Assets/PDF-DOCS/Tomlins-et-al-Rhodes-2023-Immunotherapy-Response-Score-IRS-for-PD-1-and-PD-L1-response.pdf?hsLang=en)
National Cancer Institute ([https://www.cancer.gov](https://www.cancer.gov))
## CONTACT US
## Get Started.
Have questions about how TD2 can assist with your regulatory needs? Reach out to our expert staff today to get started.
[Get Started Now](https://td2inc.com/contact-us/?hsLang=en)
×
[](https://td2inc.com/?hsLang=en)
Office
13208 E. Shea Blvd,
Suite 100
Scottsdale, AZ 85259
Phone
(602) 358-8300
Connect with us
-
-
© 2026 Translational Drug Development. All Rights Reserved. [Terms and Conditions](https://td2inc.com/terms-and-conditions?hsLang=en) | [Privacy Policy](https://td2inc.com/privacy-policy?hsLang=en)